$106.97
0.47%
Downside
Day's Volatility :0.91%
Upside
0.45%
29.01%
Downside
52 Weeks Volatility :77.21%
Upside
67.9%
Period | Cooper Companies Inc., The | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 29.04% | 7.5% | 0.0% |
6 Months | 11.5% | 6.9% | 0.0% |
1 Year | -64.74% | 20.9% | 0.0% |
3 Years | 8.02% | 21.0% | -21.1% |
Market Capitalization | 21.6B |
Book Value | $39.8 |
Earnings Per Share (EPS) | 1.8 |
PE Ratio | 60.23 |
PEG Ratio | 11.13 |
Wall Street Target Price | 113.36 |
Profit Margin | 9.45% |
Operating Margin TTM | 19.2% |
Return On Assets TTM | 3.39% |
Return On Equity TTM | 4.65% |
Revenue TTM | 3.8B |
Revenue Per Share TTM | 19.14 |
Quarterly Revenue Growth YOY | 7.8% |
Gross Profit TTM | 2.4B |
EBITDA | 1.0B |
Diluted Eps TTM | 1.8 |
Quarterly Earnings Growth YOY | 0.21 |
EPS Estimate Current Year | 3.66 |
EPS Estimate Next Year | 4.08 |
EPS Estimate Current Quarter | 0.91 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 5.97%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↑ 18.41% |
Net Income | 139.9M | ↓ 62.48% |
Net Profit Margin | 5.52% | ↓ 11.91% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.7B | ↑ 4.76% |
Net Income | 466.7M | ↑ 233.6% |
Net Profit Margin | 17.59% | ↑ 12.07% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↓ 8.39% |
Net Income | 238.4M | ↓ 48.92% |
Net Profit Margin | 9.81% | ↓ 7.78% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.9B | ↑ 20.22% |
Net Income | 2.9B | ↑ 1135.19% |
Net Profit Margin | 100.76% | ↑ 90.95% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.3B | ↑ 13.2% |
Net Income | 385.8M | ↓ 86.9% |
Net Profit Margin | 11.66% | ↓ 89.1% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.6B | ↑ 8.61% |
Net Income | 294.2M | ↓ 23.74% |
Net Profit Margin | 8.19% | ↓ 3.47% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 877.4M | ↑ 2.2% |
Net Income | 39.8M | ↓ 52.96% |
Net Profit Margin | 4.54% | ↓ 5.31% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 930.2M | ↑ 6.02% |
Net Income | 85.3M | ↑ 114.32% |
Net Profit Margin | 9.17% | ↑ 4.63% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 927.1M | ↓ 0.33% |
Net Income | 84.5M | ↓ 0.94% |
Net Profit Margin | 9.11% | ↓ 0.06% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 931.6M | ↑ 0.49% |
Net Income | 81.2M | ↓ 3.91% |
Net Profit Margin | 8.72% | ↓ 0.39% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 942.6M | ↑ 1.18% |
Net Income | 88.9M | ↑ 9.48% |
Net Profit Margin | 9.43% | ↑ 0.71% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.0B | ↑ 6.39% |
Net Income | 104.7M | ↑ 17.77% |
Net Profit Margin | 10.44% | ↑ 1.01% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↑ 25.81% |
Total Liabilities | 2.8B | ↑ 66.68% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.3B | ↑ 2.65% |
Total Liabilities | 2.6B | ↓ 5.67% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.7B | ↑ 7.38% |
Total Liabilities | 2.9B | ↑ 10.08% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 9.6B | ↑ 42.58% |
Total Liabilities | 2.7B | ↓ 8.53% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 11.5B | ↑ 19.63% |
Total Liabilities | 4.3B | ↑ 62.06% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 11.7B | ↑ 1.45% |
Total Liabilities | 4.1B | ↓ 4.86% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 11.5B | ↓ 0.19% |
Total Liabilities | 4.2B | ↓ 1.51% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 11.7B | ↑ 1.37% |
Total Liabilities | 4.2B | ↑ 0.18% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 11.7B | ↓ 0.33% |
Total Liabilities | 4.1B | ↓ 1.46% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 12.0B | ↑ 3.21% |
Total Liabilities | 4.3B | ↑ 5.58% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 12.0B | ↑ 0.12% |
Total Liabilities | 4.2B | ↓ 2.16% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 12.1B | ↑ 0.5% |
Total Liabilities | 4.2B | ↓ 1.43% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 668.9M | ↑ 12.69% |
Investing Cash Flow | -1.5B | ↑ 297.98% |
Financing Cash Flow | 844.4M | ↓ 470.51% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 713.2M | ↑ 6.62% |
Investing Cash Flow | -351.3M | ↓ 76.85% |
Financing Cash Flow | -351.4M | ↓ 141.62% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 486.6M | ↓ 31.77% |
Investing Cash Flow | -364.5M | ↑ 3.76% |
Financing Cash Flow | -95.5M | ↓ 72.82% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 738.6M | ↑ 51.79% |
Investing Cash Flow | -450.3M | ↑ 23.54% |
Financing Cash Flow | -311.4M | ↑ 226.07% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 692.4M | ↓ 6.26% |
Investing Cash Flow | -1.8B | ↑ 306.66% |
Financing Cash Flow | 1.2B | ↓ 483.33% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 607.5M | ↓ 12.26% |
Investing Cash Flow | -449.0M | ↓ 75.48% |
Financing Cash Flow | -173.9M | ↓ 114.57% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 124.2M | ↓ 25.45% |
Investing Cash Flow | -82.0M | ↓ 27.63% |
Financing Cash Flow | -46.8M | ↓ 39.69% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 142.5M | ↑ 14.73% |
Investing Cash Flow | -288.2M | ↑ 251.46% |
Financing Cash Flow | -43.0M | ↓ 8.12% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 174.2M | ↑ 22.25% |
Investing Cash Flow | -160.8M | ↓ 44.21% |
Financing Cash Flow | -6.5M | ↓ 84.88% |
Sell
Neutral
Buy
Cooper Companies Inc., The is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Cooper Companies Inc., The | 4.04% | 11.5% | -64.74% | 8.02% | 50.25% |
Intuitive Surgical, Inc. | 1.62% | 28.13% | 70.56% | 51.86% | 183.93% |
Resmed Inc. | -0.32% | 31.22% | 68.84% | -4.27% | 87.37% |
Becton, Dickinson And Company | -0.45% | -1.02% | -6.88% | 0.23% | -3.91% |
West Pharmaceutical Services Inc | -1.31% | -22.47% | -18.62% | -26.76% | 114.12% |
Alcon Ag | 4.57% | 19.02% | 34.87% | 27.87% | 76.61% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Cooper Companies Inc., The | 60.23 | 60.23 | 11.13 | 3.66 | 0.05 | 0.03 | NA | 39.8 |
Intuitive Surgical, Inc. | 83.28 | 83.28 | 4.2 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
Resmed Inc. | 35.23 | 35.23 | 2.05 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
Becton, Dickinson And Company | 48.22 | 48.22 | 1.11 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
West Pharmaceutical Services Inc | 44.27 | 44.27 | 5.2 | 6.51 | 0.2 | 0.11 | 0.0 | 35.49 |
Alcon Ag | 44.88 | 44.88 | 3.71 | 3.05 | 0.05 | 0.03 | 0.0 | 42.35 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Cooper Companies Inc., The | Buy | $21.6B | 50.25% | 60.23 | 9.45% |
Intuitive Surgical, Inc. | Buy | $172.8B | 183.93% | 83.28 | 27.65% |
Resmed Inc. | Buy | $35.9B | 87.37% | 35.23 | 21.79% |
Becton, Dickinson And Company | Buy | $69.7B | -3.91% | 48.22 | 7.13% |
West Pharmaceutical Services Inc | Buy | $22.6B | 114.12% | 44.27 | 18.25% |
Alcon Ag | Buy | $49.3B | 76.61% | 44.88 | 11.44% |
Insights on Cooper Companies Inc., The
Revenue is up for the last 4 quarters, 927.1M → 1.00B (in $), with an average increase of 2.6% per quarter
Netprofit is up for the last 3 quarters, 81.2M → 104.7M (in $), with an average increase of 11.9% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 70.6% return, outperforming this stock by 135.3%
In the last 3 years, Intuitive Surgical, Inc. has given 46.0% return, outperforming this stock by 40.1%
Vanguard Group Inc
BlackRock Inc
State Street Corp
Kayne Anderson Rudnick Investment Management LLC
T. Rowe Price Investment Management,Inc.
AllianceBernstein L.P.
In the quarter ending March,2023. Cooper Companies Inc., The has declared dividend of $0.03
Read Morecompany overview the cooper companies, inc. ("cooper") is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.
Organization | Cooper Companies Inc., The |
Employees | 15000 |
CEO | Mr. Albert G. White III |
Industry | Health Technology |